Palvella Therapeutics (PVLA) Net Margin (QoQ) (2014 - 2024)
Palvella Therapeutics (PVLA) Net Margin (QoQ) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -461,573.00 |
| Dec 31, 2023 | -47,217.00 |
| Sep 30, 2023 | -7,084.00 |
| Jun 30, 2023 | 80,436.00 |
| Mar 31, 2023 | 819,540.00 |
| Dec 31, 2022 | -408,189.00 |
| Sep 30, 2022 | 71,166.00 |
| Jun 30, 2022 | -554,841.00 |
| Mar 31, 2022 | 6,524.00 |
| Dec 31, 2021 | 34,485.00 |
| Sep 30, 2021 | 184,692.00 |
| Jun 30, 2021 | -228,604.00 |
| Mar 31, 2021 | -41,519.00 |
| Dec 31, 2020 | 89,839.00 |
| Sep 30, 2020 | -47,942.00 |
| Jun 30, 2020 | -1,674.00 |
| Mar 31, 2020 | -2,688.00 |
| Dec 31, 2019 | 1,266.00 |
| Sep 30, 2019 | 20,339.00 |
| Jun 30, 2019 | -9,942.00 |